Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis

Gut

Volumn 52, Issue 4, 2003, Pages 535-540

  Saito, H ^a   Fukuda, Y ^b   Katsuragi, K ^a   Tanaka, M ^a   Satomi, M ^b   Shimoyama, T ^b   Saito, T ^a   Tachikawa, T ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MULTIPLE ANTIGENIC PEPTIDE; PEPTIDE; PROTEIN CDP 1; PROTEIN CDP 2; PROTEIN CDP 3; PROTEIN CDP 4; PROTEIN CDP 5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN ISOLATION; SEQUENCE HOMOLOGY; ULCERATIVE COLITIS;

AMINO ACID SEQUENCE; AUTOANTIBODIES; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; ROC CURVE; SEROLOGIC TESTS;

EID: 0037378890     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.4.535     Document Type: Article

References (25)

1. Leichtner AM, Jackson WD, Grand RJ. Crohn's disease. In: Walker W, ed. Pediatric Gastrointestinal Disease, vol I, 2nd edn. St Louis: Mosby, 1996:692-711.
2. Leichtner AM, Jackson WD, Grand RJ. Ulcerative colitis. In: Walker W, ed. Pediatric Gastrointestinal Disease, vol I, 2nd edn. St Louis: Mosby, 1996:712-25.
3. Seidman E. Inflammatory bowel diseases. In: Roy CC, Silverman A, Alagille D, eds. Pediatric Clinical Gastroenterology. St Louis: Mosby, 1995:417-93.
4. Kirschner BS. Ulcerative colitis in children. Pediatr Clin North Am 1996;43:235-54.
5. Schoetz DJ Jr, Coller JA, Veidenheimer MC. Ileoanal reservoir for ulcerative colitis and familial polyposis. Arch Surg 1986;121:404-9.
6. Fonkalsrud EW, Loar N. Long-term results after colectomy and endorectal ileal pullthrough procedure in children. Ann Surg 1992;215:57-62.
7. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42:788-91.
8. Panaccione R, Sandborn WJ, Colombel JF. Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology 1999;116:1001-3.
9. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
10. Seibold F, Weber P, Jenss H, et al. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut 1991;32:1192-7.
11. H3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. J Immunol 1996;3:219-26.
12. Stevens TR J, Harley SL, Groom JS, et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 1993;38:426-32.
13. Stoffel MP, Csernok E, Herzberg C, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996;104:54-9.
14. Takahasi F, Shah HS, Wise LS, et al. Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis. Gut 1990;31:1016-20.
15. Doorbar J, Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. J Mol Biol 1994;244:361-9.
16. Naidu BR, Ngeow YF, Wang LF, et al. An immunogenic epitope of Chlamydia pneumoniae from a random phage display peptide library is reactive with both monoclonal antibody and patients sera. Immunol Lett 1998;62:111-15.
17. Dybwad A, Forre Ø, Kjeldsen-Kragh J, et al. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur J Immunol 1993;23:3189-93.
18. Fakhfakh F, Ayadi H, Bahloul Z, et al. Antibody epitopes probed by immunoselected phage-display library peptides in members of a family with various rheumatic manifestations. Clin Exp Rheumatol 1996;14:607-11.
19. Mennuni C, Santini C, Dotta F, et al. Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes. J Autoimmun 1996;9:431-6.
20. Gevorkian G, Manoutcharian K, Almagro JC, et al. Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library. Clin Immunol Immunopathol 1998;86:305-9.
21. Takahashi S, Machikawa F, Noda A, et al. Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection. Clin Diagn Lab Immunol 1998;5:24-7.
22. Felici F, Castagnoli L, Musacchio A, et al. Selectian of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 1991;222:301-10.
23. Sugi K, Saitoh O, Matsuse R, et al. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol 1999;94:1304-12.
24. Takayuki M, Nobuhide O, Fumihiko H, et al. Anti Saccharamyces cerevisiae antibody in inflammatory bowel disease. Annual Report of the Research Committee of Inflammatory Bowel Disease. Japan: The Ministry of Health and Welfare of Japan, 1999:101-3.
25. Vermeire S, Joossens S, Peeters M, et al. Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-33.